In Brief Dana-Farber joins the Parker Institute for Cancer Immunotherapy October 20, 2017Vol.43 No.39
In Brief Salk’s Evans receives $2.5 million SU2C grant for pancreatic cancer clinical trial October 20, 2017Vol.43 No.39
In Brief NIH awards Mayo Clinic researchers $3.4 million glioblastoma grant October 20, 2017Vol.43 No.39
In Brief Gene therapy group awards $1.3 million for research in glioblastoma, sarcoma, and ovarian cancer October 20, 2017Vol.43 No.39
Conversation with The Cancer Letter Rosenberg: Yescarta is going to be lifesaving for patients with lymphomas October 20, 2017Vol.43 No.39By Matthew Bin Han Ong
FDA approves Kite’s CAR-T cell therapy; another win for NCI’s intramural program October 20, 2017Vol.43 No.39By Matthew Bin Han Ong
Conversation with The Cancer Letter UPMC’s Ferris: “Now there are more system-wide pressures to make a budget and to monitor quality” October 20, 2017Vol.43 No.39By Paul Goldberg
